|
NCOA7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.27860000000014E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.153980E-04 |
| Normal-vs-Stage2 |
7.52540000000801E-05 |
| Normal-vs-Stage3 |
2.011800E-04 |
| Normal-vs-Stage4 |
8.05520000000115E-05 |
| Stage1-vs-Stage2 |
5.742400E-01 |
| Stage1-vs-Stage3 |
5.991600E-01 |
| Stage1-vs-Stage4 |
6.579800E-01 |
| Stage2-vs-Stage3 |
3.454400E-01 |
| Stage2-vs-Stage4 |
9.189400E-01 |
| Stage3-vs-Stage4 |
4.762400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.25150000000052E-05 |
| Normal-vs-AfricanAmerican |
1.646210E-04 |
| Normal-vs-Asian |
1.478860E-03 |
| Caucasian-vs-AfricanAmerican |
6.922200E-01 |
| Caucasian-vs-Asian |
8.709800E-01 |
| AfricanAmerican-vs-Asian |
8.131400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.27570000000044E-05 |
| Normal-vs-Female |
6.155300E-04 |
| Male-vs-Female |
1.558410E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.976870E-04 |
| Normal-vs-Extreme_Weight |
3.57800000000408E-05 |
| Normal-vs-Obese |
2.424900E-04 |
| Normal-vs-Extreme_Obese |
3.52550000000118E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.441180E-01 |
| Normal_Weight-vs-Obese |
7.764400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.654250E-01 |
| Extreme_Weight-vs-Obese |
3.956300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.247400E-01 |
| Obese-vs-Extreme_Obese |
7.190100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.010300E-04 |
| Normal-vs-Age(41-60Yrs) |
8.20950000000042E-05 |
| Normal-vs-Age(61-80Yrs) |
8.4905000000024E-05 |
| Normal-vs-Age(81-100Yrs) |
4.03610000000443E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.850200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.144200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.905400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.855600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.801200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.201000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.81980000000448E-05 |
| Normal-VS-Type2 PRCC |
1.417460E-04 |
| Normal-VS-KIRP CIMP |
8.735400E-03 |
| Normal-VS-Unclassified PRCC |
5.59119999999913E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.057200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.841700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.011200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.329370E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.143600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.675780E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.36909999999924E-05 |
| Normal-vs-N1 |
7.172100E-04 |
| Normal-vs-N2 |
1.397220E-03 |
| N0-vs-N1 |
3.560000E-03 |
| N0-vs-N2 |
2.465000E-01 |
| N1-vs-N2 |
7.422000E-01 |
|
|
